Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90


Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking.

Scher N, Bollet M, Bouilhol G, Tannouri R, Khemiri I, Vouillaume A, Sellami N, Von Eyben R, Vannetzel JM, Darmon I, Rotenberg L, Lamallem H, Bauduceau O, Foster D, Toledano A.

Radiat Oncol. 2019 Sep 13;14(1):167. doi: 10.1186/s13014-019-1373-2.


French-style genetics v. 2.0: The "e-CohortE" project.

Stoeklé HC, Bollet M, Cobat A, Charlier P, Bloch OC, Flatot J, Draghi C, Tolyan V, Hervé C, Desvaux P, Uzan L, Grynberg M, Alcaïs A, Tolédano A, Vogt G.

Clin Genet. 2019 Oct;96(4):330-340. doi: 10.1111/cge.13595. Epub 2019 Jul 11.


A Wake-Up Call for Routine Morbidity and Mortality Review Meeting Procedures as Part of a Quality Governance Programs in Radiation Therapy Departments: Results of the PROUST Survey.

Belkacemi Y, Colson-Durand L, Fayolle-Campana M, Pons P, Rialland A, Bastuji-Garin S, Hoang QN, Lerouge D, Jaffré F, Bollet M, Azria D.

Pract Radiat Oncol. 2019 Mar;9(2):108-114. doi: 10.1016/j.prro.2018.09.004. Epub 2018 Sep 28.


Classic Kaposi Sarcoma: An Exceptional Cause of Adrenal Incidentaloma.

de Risi-Pugliese T, Genc S, Bertherat J, Larousserie F, Bollet M, Bassi C, Dupin N.

J Endocr Soc. 2017 May 5;1(6):737-741. doi: 10.1210/js.2017-00149. eCollection 2017 Jun 1.


[Prospective: How will renal, prostatic and urothelial tumours be treated in 10 years?]

Toledano A, Bourmech M, Lamallem H, Bollet M, Bauduceau O, Pujol P, Bloch P, Khayat D.

Nephrol Ther. 2017 Apr;13 Suppl 1:S115-S125. doi: 10.1016/j.nephro.2017.01.013. Review. French.


[Radiotherapy of breast cancer].

Hennequin C, Barillot I, Azria D, Belkacémi Y, Bollet M, Chauvet B, Cowen D, Cutuli B, Fourquet A, Hannoun-Lévi JM, Leblanc M, Mahé MA.

Cancer Radiother. 2016 Sep;20 Suppl:S139-46. doi: 10.1016/j.canrad.2016.07.025. Epub 2016 Aug 10. French.


Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.

Torres-Roca JF, Fulp WJ, Caudell JJ, Servant N, Bollet MA, van de Vijver M, Naghavi AO, Harris EE, Eschrich SA.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):631-8. doi: 10.1016/j.ijrobp.2015.06.021. Epub 2015 Jun 25.


Comparison between two different algorithms used for pretreatment QA via aSi portal images.

Merheb C, Chevillard C, Ksouri W, Fawzi M, Bollet M, Toledano A.

J Appl Clin Med Phys. 2015 May 8;16(3):5202. doi: 10.1120/jacmp.v16i3.5202.


Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer.

Pernin V, Belin L, Cottu P, Bontemps P, Lemanski C, De La Lande B, Baumann P, Missohou F, Levy C, Peignaux K, Reynaud-Bougnoux A, Denis F, Gobillion A, Bollet M, Vago NA, Dendale R, Campana F, Fourquet A, Kirova YM.

Br J Radiol. 2015 Apr;88(1048):20140800. doi: 10.1259/bjr.20140800. Epub 2015 Feb 3.


Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer.

Pernin V, Belin L, Cottu P, Bontemps P, Lemanski C, De La Lande B, Baumann P, Missohou F, Levy C, Peignaux K, Bougnoux P, Denis F, Bollet M, Dendale R, Vago NA, Campana F, Fourquet A, Kirova YM.

Breast. 2014 Dec;23(6):816-20. doi: 10.1016/j.breast.2014.08.015. Epub 2014 Sep 26.


Management of somatic pain induced by head-and-neck cancer treatment: definition and assessment. Guidelines of the French Oto-Rhino-Laryngology- Head and Neck Surgery Society (SFORL).

Binczak M, Navez M, Perrichon C, Blanchard D, Bollet M, Calmels P, Couturaud C, Dreyer C, Espitalier F, Testelin S, Albert S, Morinière S; SFORL Work Group.

Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Sep;131(4):243-7. doi: 10.1016/j.anorl.2014.07.003. Epub 2014 Aug 6.


Management of somatic pain induced by treatment of head and neck cancer: Postoperative pain. Guidelines of the French Oto-Rhino-Laryngology--Head and Neck Surgery Society (SFORL).

Espitalier F, Testelin S, Blanchard D, Binczak M, Bollet M, Calmels P, Couturaud C, Dreyer C, Navez M, Perrichon C, Morinière S, Albert S; SFORL Work Group.

Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Sep;131(4):249-52. doi: 10.1016/j.anorl.2014.05.002. Epub 2014 Aug 5.


Management of somatic pain induced by head and neck cancer treatment: pain following radiation therapy and chemotherapy. Guidelines of the French Otorhinolaryngology Head and Neck Surgery Society (SFORL).

Blanchard D, Bollet M, Dreyer C, Binczak M, Calmels P, Couturaud C, Espitalier F, Navez M, Perrichon C, Testelin S, Albert S, Morinière S; SFORL Work Group.

Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Sep;131(4):253-6. doi: 10.1016/j.anorl.2014.07.001. Epub 2014 Aug 4.


Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma.

Daveau C, Baulies S, Lalloum M, Bollet M, Sigal-Zafrani B, Sastre X, Vincent-Salomon A, Tardivon A, Thibault F, Pierga JY, Cottu P, Sablin MP, Rouzier R, Malhaire C, Mallon P, Reyal F.

Br J Cancer. 2014 Apr 29;110(9):2195-200. doi: 10.1038/bjc.2014.143. Epub 2014 Apr 8.


Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.

Guillot E, Vaysse C, Goetgeluck J, Falcou MC, Couturaud B, Fitoussi A, Fourchotte V, Laki F, Malhaire C, Sigal-Zafrani B, Sastre-Garau X, Bollet MA, Mosseri V, Reyal F.

Breast. 2014 Apr;23(2):97-103. doi: 10.1016/j.breast.2013.12.002. Epub 2013 Dec 31.


Loss of heterozygosity at 13q13 and 14q32 predicts BRCA2 inactivation in luminal breast carcinomas.

Pécuchet N, Popova T, Manié E, Lucchesi C, Battistella A, Vincent-Salomon A, Caux-Moncoutier V, Bollet M, Sigal-Zafrani B, Sastre-Garau X, Stoppa-Lyonnet D, Stern MH.

Int J Cancer. 2013 Dec 15;133(12):2834-42. doi: 10.1002/ijc.28315. Epub 2013 Jul 10.


Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.

Reyal F, Hajage D, Savignoni A, Feron JG, Bollet MA, Kirova Y, Fourquet A, Pierga JY, Cottu P, Dieras V, Fourchotte V, Laki F, Alran S, Asselain B, Vincent-Salomon A, Sigal-Zafrani B, Sastre-Garau X.

PLoS One. 2013;8(3):e55901. doi: 10.1371/journal.pone.0055901. Epub 2013 Mar 19.


[Prospective monocentric study of the toxicity and the efficacy of concurrent trastuzumab and radiotherapy].

Jacob J, Belin L, Gobillion A, Daveau-Bergerault C, Dendale R, Beuzeboc P, Campana F, Bollet MA, Fourquet A, Kirova YM.

Cancer Radiother. 2013 Jun;17(3):183-90. doi: 10.1016/j.canrad.2012.12.006. Epub 2013 Mar 15. French.


Infiltrating lobular breast cancer: truly a separate entity! Consequences for radiation therapy.

Poortmans PM, Bollet M, Van Limbergen E.

Radiother Oncol. 2013 Jan;106(1):1-4. doi: 10.1016/j.radonc.2012.12.010. Epub 2013 Jan 22.


[A case of cutaneous mammary re-irradiation].

Jacob J, Pierga JY, Fourchotte V, Kirova YM, Bollet MA.

Cancer Radiother. 2012 Oct;16(7):638-40. doi: 10.1016/j.canrad.2012.08.002. Epub 2012 Oct 23. French.


Adjuvant radiotherapy in the management of axillary node negative invasive breast cancer: a qualitative systematic review.

Bourgier C, Aimard L, Bodez V, Bollet MA, Cutuli B, Franck D, Hennequin C, Kirova YM, Azria D.

Crit Rev Oncol Hematol. 2013 Apr;86(1):33-41. doi: 10.1016/j.critrevonc.2012.09.010. Epub 2012 Oct 22. Review.


[Role of hypofractionated radiotherapy in the treatment of prostate cancer: a review].

Toledano A, Beley S, Bollet M, Lamallem H, Zerbib M, Rouprêt M.

Prog Urol. 2012 Oct;22(12):671-7. doi: 10.1016/j.purol.2012.04.002. Epub 2012 May 10. Review. French.


Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation.

Popova T, Manié E, Rieunier G, Caux-Moncoutier V, Tirapo C, Dubois T, Delattre O, Sigal-Zafrani B, Bollet M, Longy M, Houdayer C, Sastre-Garau X, Vincent-Salomon A, Stoppa-Lyonnet D, Stern MH.

Cancer Res. 2012 Nov 1;72(21):5454-62. doi: 10.1158/0008-5472.CAN-12-1470. Epub 2012 Aug 29.


Concurrent use of aromatase inhibitors and hypofractionated radiation therapy.

Chargari C, Castro-Pena P, Toledano I, Bollet MA, Savignoni A, Cottu P, Laki F, Campana F, De Cremoux P, Fourquet A, Kirova YM.

World J Radiol. 2012 Jul 28;4(7):318-23. doi: 10.4329/wjr.v4.i7.318.


New strategy in hepatic metastatic colorectal cancer: tomotherapy and capecitabine followed by hepatic surgical resection.

Cacheux W, Bollet MA, Servois V, Zefkili S, Farkhondeh F, Baranger B, Mariani P.

Med Oncol. 2012 Dec;29(5):3143-6. doi: 10.1007/s12032-012-0311-z. Epub 2012 Aug 2.


Prospective and comparative evaluation of the toxicity of adjuvant concurrent chemoradiotherapy after neoadjuvant chemotherapy for breast cancer.

Marchand V, Angelergues A, Gobaux V, Hajage D, Kirova YM, Campana F, Dendale R, Reyal F, Pierga JY, Fourquet A, Bollet MA.

Am J Clin Oncol. 2013 Oct;36(5):425-9. doi: 10.1097/COC.0b013e31825466a6.


Respective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinoma.

Reyal F, Bollet MA, Caly M, Gentien D, Carpentier S, Peyro-Saint-Paul H, Pierga JY, Cottu P, Dieras V, Sigal-Zafrani B, Vincent-Salomon A, Sastre-Garau X.

PLoS One. 2012;7(4):e35184. doi: 10.1371/journal.pone.0035184. Epub 2012 Apr 18. Erratum in: PLoS One. 2012;7(7). doi: 10.1371/annotation/46dc7048-61b1-45bd-b4cd-a3b80a2f3f5a.


[Breast conserving surgery in locoregional treatment of breast carcinoma after Hodgkin lymphoma].

Haberer S, Belin L, Le Scodan R, Kirova YM, Savignoni A, Stevens D, Moisson P, Decaudin D, Pierga JY, Reyal F, Campana F, Fourquet A, Bollet MA.

Cancer Radiother. 2012 Apr;16(2):128-35. doi: 10.1016/j.canrad.2011.10.013. Epub 2012 Feb 15. French.


Search for a gene expression signature of breast cancer local recurrence in young women.

Servant N, Bollet MA, Halfwerk H, Bleakley K, Kreike B, Jacob L, Sie D, Kerkhoven RM, Hupé P, Hadhri R, Fourquet A, Bartelink H, Barillot E, Sigal-Zafrani B, van de Vijver MJ.

Clin Cancer Res. 2012 Mar 15;18(6):1704-15. doi: 10.1158/1078-0432.CCR-11-1954. Epub 2012 Jan 23.


External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement.

Hajage D, de Rycke Y, Bollet M, Savignoni A, Caly M, Pierga JY, Horlings HM, Van de Vijver MJ, Vincent-Salomon A, Sigal-Zafrani B, Senechal C, Asselain B, Sastre X, Reyal F.

PLoS One. 2011;6(11):e27446. doi: 10.1371/journal.pone.0027446. Epub 2011 Nov 8.


Preoperative radio-chemotherapy in early breast cancer patients: long-term results of a phase II trial.

Bollet MA, Belin L, Reyal F, Campana F, Dendale R, Kirova YM, Thibault F, Diéras V, Sigal-Zafrani B, Fourquet A.

Radiother Oncol. 2012 Jan;102(1):82-8. doi: 10.1016/j.radonc.2011.08.017. Epub 2011 Sep 8.


[Role of locoregional radiation therapy in breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy. The Institut Curie-Hôpital René-Huguenin experience].

Le Scodan R, Bruant S, Selz J, Bollet MA, Daveau C, de la Lande B, Lerebours F, Labib A, Stevens D.

Cancer Radiother. 2011 Dec;15(8):675-82. doi: 10.1016/j.canrad.2011.04.004. Epub 2011 Aug 9. French.


[Management of inflammatory breast cancer after neo-adjuvant chemotherapy].

Abrous-Anane S, Savignoni A, Daveau C, Pierga JY, Gautier C, Reyal F, Dendale R, Campana F, Kirova Y, Fourquet A, Bollet MA.

Cancer Radiother. 2011 Dec;15(8):654-62. doi: 10.1016/j.canrad.2011.01.009. Epub 2011 Aug 5. French.


The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma.

Reyal F, Rouzier R, Depont-Hazelzet B, Bollet MA, Pierga JY, Alran S, Salmon RJ, Fourchotte V, Vincent-Salomon A, Sastre-Garau X, Antoine M, Uzan S, Sigal-Zafrani B, De Rycke Y.

PLoS One. 2011;6(5):e20297. doi: 10.1371/journal.pone.0020297. Epub 2011 May 31.


Preliminary experience of whole-brain radiation therapy (WBRT) in breast cancer patients with brain metastases previously treated with bevacizumab-based chemotherapy.

Chira C, Jacob J, Derhem N, Bollet MA, Campana F, Marchand V, Pierga JY, Fourquet A, Kirova YM.

J Neurooncol. 2011 Nov;105(2):401-8. doi: 10.1007/s11060-011-0607-4. Epub 2011 Jun 5.


Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial.

Kirova YM, Fromantin I, De Rycke Y, Fourquet A, Morvan E, Padiglione S, Falcou MC, Campana F, Bollet MA.

Radiother Oncol. 2011 Aug;100(2):205-9. doi: 10.1016/j.radonc.2011.05.014. Epub 2011 May 31.


Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.

Haberer S, Belin L, Le Scodan R, Kirova YM, Savignoni A, Stevens D, Moisson P, Decaudin D, Pierga JY, Reyal F, Campana F, Fourquet A, Bollet MA.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e145-52. doi: 10.1016/j.ijrobp.2011.03.013. Epub 2011 May 24.


[Concurrent whole-brain radiotherapy with trastuzumab for treatment of brain metastases in breast cancer patients: questions and answers].

Riahi Idrissi H, Chargari C, Bollet MA, Le Scodan R, Olivier L, Dorval T, Marchand V, Cottu P, Dieras V, Campana F, Fourquet A, Kirova YM.

Bull Cancer. 2011 Apr;98(4):425-32. doi: 10.1684/bdc.2011.1342. Review. French.


[Radiotherapy for breast cancer and pacemaker].

Menard J, Campana F, Kirov KM, Bollet MA, Dendale R, Fournier-Bidoz N, Marchand V, Mazal A, Estève M, Fourquet A, Kirova YM.

Cancer Radiother. 2011 Jun;15(3):197-201. doi: 10.1016/j.canrad.2010.11.014. Epub 2011 Mar 21. French.


Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy.

Le Scodan R, Selz J, Stevens D, Bollet MA, de la Lande B, Daveau C, Lerebours F, Labib A, Bruant S.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e1-7. doi: 10.1016/j.ijrobp.2010.12.054. Epub 2011 Mar 4.


Management of phyllodes breast tumors.

Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, Laé M, Bollet M, Pierga JY, Salmon R, Fitoussi A; Breast Cancer Study Group of the Institut Curie.

Breast J. 2011 Mar-Apr;17(2):129-37. doi: 10.1111/j.1524-4741.2010.01045.x. Epub 2011 Jan 19.


[Early stage breast cancer: is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?].

Daveau C, Savignoni A, Abrous-Anane S, Pierga JY, Reyal F, Gautier C, Kirova YM, Dendale R, Campana F, Fourquet A, Bollet MA.

Cancer Radiother. 2011 Apr;15(2):106-14. doi: 10.1016/j.canrad.2010.06.020. Epub 2010 Nov 16. French.


Preliminary results of whole brain radiotherapy with concurrent trastuzumab for treatment of brain metastases in breast cancer patients.

Chargari C, Idrissi HR, Pierga JY, Bollet MA, Diéras V, Campana F, Cottu P, Fourquet A, Kirova YM.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):631-6. doi: 10.1016/j.ijrobp.2010.06.057. Epub 2010 Oct 6.


Cardiac toxicity in breast cancer patients: from a fractional point of view to a global assessment.

Chargari C, Kirov KM, Bollet MA, Magné N, Védrine L, Cremades S, Beuzeboc P, Fourquet A, Kirova YM.

Cancer Treat Rev. 2011 Jun;37(4):321-30. doi: 10.1016/j.ctrv.2010.08.007. Epub 2010 Sep 22. Review.


The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: a single-institution study.

Caussa L, Kirova YM, Gault N, Pierga JY, Savignoni A, Campana F, Dendale R, Fourquet A, Bollet MA.

Eur J Cancer. 2011 Jan;47(1):65-73. doi: 10.1016/j.ejca.2010.08.013. Epub 2010 Sep 16.


Prognostic factors for local recurrence following breast-conserving treatment in young women.

Bollet MA, Kirova YM, Fourquet A, de Cremoux P, Reyal F.

Expert Rev Anticancer Ther. 2010 Aug;10(8):1215-27. doi: 10.1586/era.10.67. Review.


Targeting poly(ADP-ribose) polymerase activity for cancer therapy.

Mégnin-Chanet F, Bollet MA, Hall J.

Cell Mol Life Sci. 2010 Nov;67(21):3649-62. doi: 10.1007/s00018-010-0490-8. Epub 2010 Aug 20. Review.


Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis.

Letouzé E, Allory Y, Bollet MA, Radvanyi F, Guyon F.

Genome Biol. 2010;11(7):R76. doi: 10.1186/gb-2010-11-7-r76. Epub 2010 Jul 22.


Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?

Daveau C, Savignoni A, Abrous-Anane S, Pierga JY, Reyal F, Gautier C, Kirova YM, Dendale R, Campana F, Fourquet A, Bollet MA.

Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1452-9. doi: 10.1016/j.ijrobp.2010.01.003. Epub 2010 Jun 3.


The impact of the loco-regional treatment in elderly breast cancer patients: hypo-fractionated exclusive radiotherapy, single institution long-term results.

Chargari C, Kirova YM, Laki F, Savignoni A, Dorval T, Dendale R, Bollet MA, Fourquet A, Campana F; Institut Curie Breast Cancer Study Group.

Breast. 2010 Oct;19(5):413-6. doi: 10.1016/j.breast.2010.04.004. Epub 2010 May 18.

Supplemental Content

Loading ...
Support Center